Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: a systematic review and meta-analysis

Joustra, Monica L.; Minovíc, Isidor; Janssens, Karin A.M.; Bakker, S.J.L.; Rosmalen, Judith

doi:10.1016/j.jpsychores.2016.03.165

Cited by 5 publications

(4 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our data regarding the high prevalence rate of VDD among FMS patients is in agreement with previous studies [1,[10][11][12][13][14][15]. In an earlier study, Abokrysha, et al examined the vitamin D levels in 30 FMS Saudi female patients, and the data showed a mean concentration of 4.76 ± 1.46 ng/mL indicating a high prevalence of severe VDD among this population [10].…”

Section: Discussionsupporting

confidence: 92%

Untitled

2019

J Musculoskelet Disord Treat

View full text Add to dashboard Cite

Objective: To examine vitamin D levels in patients diagnosed with fibromyalgia syndrome (FMS).Methods: This study was performed at Riyadh Care Hospitals, Saudi Arabia. The data were obtained from rheumatology outpatient clinic records that routinely measure Vitamin D levels. The total number of patients in this database was 1,072. The gathered data included vitamin D serum concentration, age, and gender, as well as body mass index (BMI).Patients were diagnosed according to Wolfe, et al. criteria for diagnosing FMS. Vitamin D deficiency (VDD) was defined according to Mayo Medical Laboratories Reference Ranges for Total Serum 25-hydroxyvitamin D [25(OH)D]: Optimal: 25-80 ng/mL; mild to moderate: 10-24 ng/mL; severe: < 10 ng/mL.Results: Twenty-eight patients were included in the study. The mean age was 37.8 ± 7.0 years. The average BMI was 29.3 ± 4.22. Mean Vitamin D level was 10.23 ± 4.99 ng/ mL. The overall prevalence rate of VDD (i.e., 24 ng/mL and below) was high at 96.4% (27/28). In terms of severity, most of the patients (20/28; %) had severe VDD (i.e., below 10 ng/mL) with a prevalence rate of 71.4%. Regression analyses demonstrated that FMS patients with older age (45 and above), and higher BMI (30 and above) had a higher probability of having severe VDD. Conclusion:The condition of VDD is frequently seen in patients diagnosed with FMS. Patients with FMS, old age, and high BMI had a higher probability of having severe VDD.Although the sample size of the study is small, the figures are alarming, suggesting that practitioners' need to be vigilant regarding the testing of vitamin D serum levels in this patient population. Screening for VDD is particularly critical for patients 45 years and older or with BMI that is 30 and above.

show abstract

Section: Discussionsupporting

confidence: 92%

Untitled

2019

J Musculoskelet Disord Treat

View full text Add to dashboard Cite

show abstract

“…Reduced caloric intake and consumption of carbohydrates, proteins, lipids, vitamins A, E, K, folate, selenium, and zinc have been reported. Additionally, a positive correlation between protein intake and pain threshold, and an association between vitamin E and quality of life, has been documented [16,81,82].…”

Section: Current Treatment Of Fibromyalgiamentioning

confidence: 98%

“…However, the idea that vitamins and nutritional supplements directly correlate to the pathophysiology of the disease is one that is disputed. In fact, some research has found no statistical correlation between the use of supplementation and the effectiveness for patients [81]. One study looked to examine the correlation between monosodium glutamate (MSG) intake and the symptoms of FM; patients that discontinued the consumption of MSG tended to have similar levels of pain as those in the control group.…”

Section: The Role Of Nutrient Supplementation For Pain Management In Patients With Fibromyalgiamentioning

confidence: 99%

The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review

et al. 2021

View full text Add to dashboard Cite

Introduction:The multifaceted clinical presentation of fibromyalgia (FM) supports the modern understanding of the disorder as a more global condition than one simply affecting pain sensation. The main pharmacologic therapies used clinically include anti-epileptics and antidepressants. Conservative treatment options include exercise, myofascial release, psychotherapy, and nutrient supplementation. Methods: Narrative review. Results: Nutrient supplementation is a broadly investigated treatment modality as numerous deficiencies have been linked to FM. Additionally, a proposed link between gut microbiome patterns and chronic pain syndromes has led to studies investigating probiotics as a possible treatment. Despite positive results, much of the current evidence regarding this topic is of poor quality, with variable study designs, limited sample sizes, and lack of control groups. Conclusions: The etiology of FM is complex, and has shown to be multi-factorial with genetics and environmental exposures lending influence into its development. Preliminary results are promising, however, much of the existing evidence regarding diet supplementation is of poor quality. Further, more robust studies are needed to fully elucidate the potential of this alternative therapeutic option.

show abstract

“…Cela s'explique possiblement par la difficulté d'établir un diagnostic formel, l'absence de tests diagnostiques validés [37][38][39], et l'absence de traitement [40][41][42][43][44][45]. Le délai diagnostic moyen de 7…”

Section: Résultatsunclassified

Impact de la reconnaissance de handicap et des aménagements professionnels sur la situation professionnelle des travailleurs atteints d’Encéphalomyelite Myalgique/Syndrome de fatigue chronique (EM/SFC)

Chapal

Pénaranda

Stavris

et al. 2021

La Revue de Médecine Interne

View full text Add to dashboard Cite

Ce travail de mémoire n'aurait pas pu aboutir sans la patience, le soutien et le talent des merveilleuses personnes qui constituent mon entourage. Daphné, depuis bientôt douze ans tu es la plus attentionnée, fidèle et aimante des compagnes. Tu fais de chaque jour une nouvelle surprise et les épreuves que nous avons traversées ensemble nous ont rapprochés et renforcés; Je t'aime et te suis infiniment reconnaissant pour ton aide et ton accompagnement dans mon travail.Mes parents dont la bienveillance et la dévotion inébranlables m'ont soutenu à travers mes très longues études de médecine. Des petits déjeuners en première année, à votre soutien pendant mes années d'externat. Dans l'angoisse des révisions et la célébration de résultats. Vous avez fait de moi un médecin, du fond du coeur merci. Merci pour sa guidance et son soutien au Docteur Frédérique Retornaz . Son implication au près des patients, et son travail pour la reconnaissance de l'Encéphalo-myélite Myalgique. Merci à mes co-auteurs, Guillaume Penaranda, les docteurs Laurent Chiche et Chloé Stavris, le Pr Yves Jammes pour leurs conseils et leur appui et à Myriam Bennani pour ses conseils. Merci à tous les patients qui ont accepté de participer à mon étude et me donner l'opportunité d'accomplir mon parcours personnel et d'apporter ma maigre contribution à la reconnaissance de leurs situations. Merci à Hubert et Ria Van Beek pour les traductions néérlandaises. A L'escouade d'élite du SIMA: Stéphane jugulaire Quaranta, Eva la Collegiale Alves, Anthony Nounours Macia, Françoise Tata Gomez, Romain Pan-pan Hamel mon binôme maudit de toujours! Et à tous mes collègues de l'hopital européens. A tous mes maîtres de stages et professeurs qui m'ont appris ce merveilleux métier, Le Docteur Patrick François qui a suscité ma vocation, les Docteurs Leveque et Mizzi, les Docteurs Gilles-Cau et Danvin, l'équipe du docteur Pons d'Aubagne. La super équipe de Montolivet Laurence, Manam, Ramzi et Isabelle! Tous mes co-internes qui ont partagé le fardeau avec moi. À mes excellents amis, Flore, Manu, Claire, Kenan, Alexandre, Marie-paule, Jules, Antoine, Mes chers frère et soeurs, leurs conjoints et mes neveux et nièces qui grandissent ou ont grandi trop vite! SOMMAIRE: INTRODUCTION……………………………………………page 1 MATERIEL&METHODE…………………………………..page 5 Patients. …………………………………………….………….page 5 Données de l'enquête……………………………………………page 5 Considérations éthiques ………………………….……….…….page 7

show abstract

Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: a systematic review and meta-analysis

Abstract: Background

Cited by 5 publications

References 20 publications

Untitled

Untitled

The Role of Nutrient Supplementation in the Management of Chronic Pain in Fibromyalgia: A Narrative Review

Impact de la reconnaissance de handicap et des aménagements professionnels sur la situation professionnelle des travailleurs atteints d’Encéphalomyelite Myalgique/Syndrome de fatigue chronique (EM/SFC)

Contact Info

Product

Resources

About